Restore Vision Inc
Light at the End of the Tunnel
Kobe, United States · Founded 2019 · $2.8M raised
- Headquarters
- Kobe
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- restore-vis.com
- Total Funding
- $2.8M
- Last Round
- Series AApr 2026
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Restore Vision Inc. is a clinical-stage gene therapy company developing transformative treatments for inherited retinal diseases (IRDs) such as retinitis pigmentosa. Its lead program RV-001 uses a gene-agnostic approach — Chimeric opsin technology — to restore light sensitivity regardless of the underlying genetic mutation. The company is currently conducting Phase I/II clinical trials.
Summary
Restore Vision Inc is a Healthcare company based in Kobe, United States, founded in 2019. It has raised $2.8M in total across 3 rounds, most recently a Series A round in Apr 2026. Investors include Shionogi, Remiges Ventures and Kyoto University Innovation Capital.
Funding History
Apr 2026
Sign up to see all 3 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/restore-vision-inc"><img src="https://indexed.vc/api/badge/company/restore-vision-inc" alt="Restore Vision Inc on Indexed.vc" width="260" height="76" /></a>